SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
38.64
23-一月-25 16:45:00
15 分钟延时
股票
+0.47
+1.23%
今日范围
38.00 - 38.85
ISIN
N/A
来源
NASDAQ
-
Supernus Announces Second Quarter 2021 Financial Results
04 8月 2021 16:09:33 条件 Nasdaq GlobeNewswire
-
Supernus to Host Second Quarter 2021 Financial Results Conference Call
22 7月 2021 16:37:21 条件 Nasdaq GlobeNewswire
-
Supernus to Present at Jefferies Virtual Healthcare Conference
25 5月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
24 5月 2021 08:30:00 条件 Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2021 Financial Results
05 5月 2021 16:01:00 条件 Nasdaq GlobeNewswire
-
Supernus Announces Paragraph IV ANDA Filing for XADAGO®
04 5月 2021 20:49:10 条件 Nasdaq GlobeNewswire
-
Supernus to Host First Quarter 2021 Financial Results Conference Call
27 4月 2021 17:44:01 条件 Nasdaq GlobeNewswire
-
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
02 4月 2021 16:58:32 条件 Nasdaq GlobeNewswire
-
Supernus to Present at Cowen Healthcare Conference
26 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2020 Financial Results
25 2月 2021 16:00:00 条件 Nasdaq GlobeNewswire
-
Supernus to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call
23 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
08 2月 2021 09:00:00 条件 Nasdaq GlobeNewswire
-
Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference
06 1月 2021 17:29:08 条件 Nasdaq GlobeNewswire